Otsuka Pharmaceutical Overview

  • Year Founded
  • 1964

Year Founded

  • Status
  • Private

  • Employees
  • 35,340

Employees

  • Investors
  • 1

Otsuka Pharmaceutical General Information

Description

Manufacturer of pharmaceutical, nutrition and cosmetics products intended to cure illnesses and promote daily health. The company's products include pharmaceuticals, clinical testing equipment, medical equipment, food products and cosmetics, enabling customers access to a variety of medicines and medical products around the globe.

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 2-9, Kanda-Tsukasamachi
  • Chiyoda-ku
  • Tokyo, 101-8535
  • Japan
+81
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Drug Discovery
Vertical(s)
Corporate Office
  • 2-9, Kanda-Tsukasamachi
  • Chiyoda-ku
  • Tokyo, 101-8535
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Otsuka Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical, nutrition and cosmetics products intended to cure illnesses and promote daily health. Th
Pharmaceuticals
Tokyo, Japan
35,340 As of 2026

Rosario, Argentina

Toronto, Canada
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Otsuka Pharmaceutical Competitors (13)

One of Otsuka Pharmaceutical’s 13 competitors is Sannabis, a Corporate Backed or Acquired company based in Rosario, Argentina.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sannabis Corporate Backed or Acquired Rosario, Argentina
Growpacker Venture Capital-Backed Toronto, Canada
Grünenthal Private Equity-Backed Aachen, Germany
Vanda Pharmaceuticals Formerly VC-backed Washington, DC
Tetra Bio-Pharma Corporation Orleans, Canada
You’re viewing 5 of 13 competitors. Get the full list »

Otsuka Pharmaceutical Patents

Otsuka Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7811077-B1 Liquid nutritional composition, method for producing the same, and method for inhibiting the formation of film-like aggregates in a liquid nutritional composition Active 05-Nov-2025
WO-2026234998-A1 Spout and filter member attached to said spout Pending 07-May-2025
JP-2026178194-A Pharmaceutical composition Pending 25-Apr-2025
WO-2026216623-A1 Method for producing kaempferol Pending 11-Apr-2025
WO-2026204570-A1 System comprising orally ingestible device and sensor including magnetoresistive element Pending 28-Mar-2025
To view Otsuka Pharmaceutical’s complete patent history, request access »

Otsuka Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Otsuka Pharmaceutical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
China National Pharmaceutical Investment PE/Buyout
To view Otsuka Pharmaceutical’s complete investors history, request access »

Otsuka Pharmaceutical Investments & Acquisitions (33)

Otsuka Pharmaceutical’s most recent deal was a Merger/Acquisition with Transcend Therapeutics for . The deal was made on 12-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Transcend Therapeutics 12-Jun-2026 Merger/Acquisition Drug Discovery
Cantargia (CAN10 IL1RAP Immunology Program) 11-Sep-2025 Corporate Asset Purchase Buildings and Property
Jnana Therapeutics 08-Oct-2024 Merger/Acquisition Drug Discovery
iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) 25-Feb-2024 Corporate Asset Purchase Buildings and Property
Mindset Pharma 26-Oct-2023 Merger/Acquisition Drug Discovery
You’re viewing 5 of 33 investments and acquisitions. Get the full list »

Otsuka Pharmaceutical Affiliates

Subsidiaries (7)

Name Industry Location Year Founded
Transcend Therapeutics New York, NY 2021
Jnana Therapeutics Boston, MA 2017
Visterra Waltham, MA 2008
Astex Pharmaceuticals Cambridge, United Kingdom 1999
Claris (Holding Companies) Ahmedabad, India 1999
You’re viewing 5 of 7 affiliates. Get the full list.  »

Otsuka Pharmaceutical FAQs

  • When was Otsuka Pharmaceutical founded?

    Otsuka Pharmaceutical was founded in 1964.

  • Where is Otsuka Pharmaceutical headquartered?

    Otsuka Pharmaceutical is headquartered in Tokyo, Japan.

  • What is the size of Otsuka Pharmaceutical?

    Otsuka Pharmaceutical has 35,340 total employees.

  • What industry is Otsuka Pharmaceutical in?

    Otsuka Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Otsuka Pharmaceutical a private or public company?

    Otsuka Pharmaceutical is a Private company.

  • What is Otsuka Pharmaceutical’s current revenue?

    The current revenue for Otsuka Pharmaceutical is .

  • Who are Otsuka Pharmaceutical’s investors?

    China National Pharmaceutical Investment has invested in Otsuka Pharmaceutical.

  • Who are Otsuka Pharmaceutical’s competitors?

    Sannabis, Growpacker, Grünenthal, Vanda Pharmaceuticals, and Tetra Bio-Pharma are some of the 13 competitors of Otsuka Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process